Inventor · disambiguated record
Lauren J. Almeida
Also filed as: ALMEIDA LAUREN · ALMEIDA LAUREN J
20 granted patents·11 pending applications·81 citations·filing 2012–2025
94Inventor score
Top patents by PatentIndex Score
31 records- 0196US10130651B2RNAi Therapy for Hepatitis B Virus InfectionARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Nov 20, 2018·22 cites·18 claims
- 0295US9932586B2Compositions and methods for inhibiting gene expression of LPAARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·9 cites·39 claims
- 0394US12188017B2Compositions and methods for inhibiting gene expression of alpha-1 antitrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Jan 7, 2025·1 cites·12 claims
- 0494US11517584B2RNAi agents for Hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 6, 2022·2 cites·58 claims
- 0593US10662427B2Compositions and methods for inhibiting gene expression of LPAARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·6 cites·39 claims
- 0692US11590156B2RNAi agents for hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Feb 28, 2023·2 cites·37 claims
- 0792US10780108B2RNAi agents for Hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Sep 22, 2020·5 cites·67 claims
- 0892US9803205B2Compositions and methods for inhibiting gene expression of factor XIIARROWHEAD MADISON INC·Filed 2016·Granted Oct 31, 2017·9 cites·25 claims
- 0991US11384355B2Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Jul 12, 2022·3 cites·23 claims
- 1090US2025197861A1Compositions and methods for inhibiting gene expression of alpha-1 antitrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1189US10806750B2RNAi therapy for hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·3 cites·9 claims
- 1288US10006025B2Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsinARROWHEAD MADISON INC·Filed 2015·Granted Jun 26, 2018·5 cites·25 claims
- 1387US10308941B2Compositions and methods for inhibiting gene expression of factor XIIARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Jun 4, 2019·4 cites·26 claims
- 1486US10927373B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Feb 23, 2021·2 cites·20 claims
- 1586US9976141B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD MADISON INC·Filed 2016·Granted May 22, 2018·5 cites·32 claims
- 1686US2025115907A1Compositions and methods for inhibiting gene expression of lpaARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1781US8933047B2Poly(acrylate) polymers for in vivo nucleic acid deliveryWAKEFIELD DARREN H·Filed 2012·Granted Jan 13, 2015·3 cites·20 claims
- 1880US2023355651A1Rnai agents for hepatitis b virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1979US2023355654A1Rnai therapy for hepatitis b virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2078US12258563B2Modified oligonucleotidesEMPIRICO INC·Filed 2023·Granted Mar 25, 2025·0 cites·19 claims
- 2174US11840688B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 12, 2023·0 cites·20 claims
- 2274US10858658B2Compositions and methods for inhibiting gene expression of factor XIIARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Dec 8, 2020·0 cites·19 claims
- 2371US11534453B2RNAi therapy for hepatitis B virus infectionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·0 cites·25 claims
- 2469US2020263179A1Compositions and methods for inhibiting gene expression of lpaARROWHEAD PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2564US2019255091A1RNAi AGENTS FOR HEPATITIS B VIRUS INFECTIONARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2663US2018258430A1Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsinARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2763US2025388900A1Compositions and Methods for Inhibition of Factor XII Gene ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2862US2025250568A1Modified oligonucleotidesEMPIRICO INC·Filed 2025·Application pending·0 cites
- 2958US9452221B2Poly(acrylate) polymers for in vivo nucleic acid deliveryARROWHEAD MADISON INC·Filed 2014·Granted Sep 27, 2016·0 cites·19 claims
- 3052US2019382763A1Compositions and Methods for Inhibition of Factor XII Gene ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3141US2016272970A1RNA Interference AgentsARROWHEAD MADISON INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →